RNA sequencing and DEG analysis showed a significant enrichment of pathways involving the function of CHI3L1, suggesting a high level of activity of this protein in our CDAA-HFAT-induced NASH model. The gene discussed is CHI3L1; the disease is metabolic dysfunction-associated steatohepatitis.